Chemotherapy response analysis for osteosarcom with intra-arterial chemotherapy by subcutaneous implantable delivery system

Pathology and Oncology Research

Volumn 17, Issue 4, 2011, Pages 947-953

  Li, Dingfeng ^a   Cui, Qiu ^a   Liu, Yaosheng ^b   Wang, Xiaohong ^a   Liu, Cheng ^a   Liu, Shubin ^a   Zeng, Yanjun ^b  

^a Beijing 307 Hospital   (China)

^b BEIJING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Arterial chemotherapy; Neoadjuvant chemotherapy; Osteosarcoma; Survival rate

Indexed keywords

CISPLATIN; EPIRUBICIN;

ADOLESCENT; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE DURATION; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; IMPLANTABLE PORT SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OSTEOSARCOMA; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; EPIRUBICIN; EXTREMITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, SUBCUTANEOUS; MALE; NEOADJUVANT THERAPY; NEOPLASM STAGING; OSTEOSARCOMA; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84855430619     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9408-5     Document Type: Article

References (17)

1. Rosen G, Marcove RC, Caparros B et al (1979) Primary osteogenic sarcoma - the rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163-2192
2. Bacci G, Longhi A, Versari M et al (2006) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Fifteen year experience in 789 patients treated at a single institution. Cancer 106:1154-1161
3. Guo W, Yang RL, Tang XD et al (2004) Neoadjuvant chemotherapy for osteosarcoma. Natl Med J Chin 84:1186-1190
4. Ferrari S, Smeland S, Mercuri M, Italian and Scandinavian Sarcoma Groups et al (2005) Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, Cisplatin, and doxorubicin for patients with localized ostesarcoma of the extremity. A joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 23:8845-8852 (Pubitemid 46211531)
5. Goorin AM, Schwartzentruber DJ, Devidas M et al (2003) Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 21:1574-1580 (Pubitemid 46594112)
6. Bacci G, Ferrari S, Longhi A et al (2003) Preoperative therapy versus immediate surgery in nonmetastatic osteosarcoma. J Clin Oncol 21:4662-4663
7. Li D, Cui Q, Fan H et al (2005) Extendible replacement of the distal femur in the treatment of osteosarcoma in growing individuals. Chin J Reparative Reconstr Surg 19:560-562
8. Dahlin DC, Coventry MB (1967) Osteogenic sarcoma. A study of six hundred cases. J Bone Joint Surg Am 49:101-110
9. Lin F, Dong Y, Tang X et al (2006) Clinical analysis on efficacy and prognosis of new adjuvant chemotherapy for stageIIB osteosarcoma. Tumor 26:1011-1014
10. Rao BN, Rodriguez-Galindo C (2003) Intra-arterial cisplatin in osteosarcoma: Same question, different answer. Ann Surg Oncol 10:481-483 (Pubitemid 40486906)
11. Guo wei; Li dasen; Shen danhua et al (2006) Treatment of multifocal osteosarcoma. Chin J Orthop 26:378-380
12. Bramwell VH, Burgers MV, Souhami RL et al (1997) A randomized comparison of two short intensive chemotherapy regimens in children and young adults with osteosarcoma: Results in patients with metastases: A study of the European Osteosarcoma Intergroup. Sarcoma 1:155-160 (Pubitemid 28267184)
13. Souhami RL, CraftAW,Van der EijkenJWet al (1997) Randomised trial of two regimens of chemotherapy in operable osteosarcoma: A study of the European Osteosarcoma Intergroup. Lancet 350(9082):911-917 (Pubitemid 27420527)
14. Stewart DJ, Benjamin RS, Zimmerman S et al (1983) Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II). Cancer Res 43:917-920 (Pubitemid 13193903)
15. Jaffe N, Knapp J, Chuang VP et al (1983) Osteosarcoma: Intra-arterial treatment of the primary tumorwith cis-diammine-dichloroplatinumII (CDP). Angiographic, pathologic, and pharmacologic studies. Cancer 51:402-407 (Pubitemid 13185366)
16. Wilkins RM, Cullen JW, Camozzi AB et al (2005) Improved survival in primary nonmetastatic pediatric osteosarcoma of the extremity. Clin Orthop Relat Res 438:128-136 (Pubitemid 41254327)
17. Hugate RR, Wilkins RM, Kelly CM et al (2008) Intraarterial chemotherapy for extremity osteosarcoma and MFH in adults. Clin Orthop Relat Res 466:1292-1301